The down-regulation of GPD1L by miR-210 occurs in vivo and contributes to HIF1 stability, which enhance the metastatic and invasiveness of cancer (Costales et al., 2017; Gee et al., 2014; Kelly et al., 2011). This evidence concerns the gene HIF1A and cancer.